KabaFusion Selected by GC Biopharma USA, Inc. as a Limited Distribution Partner for Partner of ALYGLO™ for Adults With Primary Humoral Immunodeficiency (PI) CERRITOS, Calif. and LEXINGTON, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home infusion, has been selected by GC Biopharma USA, Inc. as a limited...

KabaFusion Selected by UCB as a Limited Distribution Partner for RYSTIGGO® (rozanolixizumab-noli) CERRITOS, Calif. and LEXINGTON, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home infusion, has been selected by UCB as a limited distribution partner to...

Memorial Hermann Health System Joins Existing Investors in KabaFusion, a Leading National Home Infusion Provider HOUSTON, April 10, 2023 (GLOBE NEWSWIRE) -- Memorial Hermann Health System (“Memorial Hermann”) – a non-profit, community-focused, award-winning health system committed to creating healthier Greater...